Gout
The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.
Dr. Pillinger weighs in with his view of the FAST trial (abstract L08) presented at ACR 2020.
Auckland's Dr. Dalbeth examines the cardiovascular safety in the FAST trial of feboxustat (abstract L08) presented at the ACR 2020.
On Saturday, November 7th, Drs. Cush and Kavanaugh discuss gout studies presented at ACR 2020 with Dr. Michael Pillinger and Dr. Bella Mehta.
Dr. Jack Cush interviews Dr. Ken Saag about the benefits of adding mycophenolate to your pegloticase regimen in refractory gout patients.
NYU's Dr. Pillinger talks about Dr. Ann Rosenthal's state of the art talk on calcium pyrophosphate disease at ACR 2020.
Dr. Janet Pope reviews abstract #1466 presented at the 2020 ACR annual meeting. Who has more comorbidities: OA, Gout, RA or PsA?
Dr. Jeff Curtis from UAB examines the use of Febuxostat (abstract L08) presented at the 2020 ACR annual meeting.
Dr. Dalbeth examines abstracts #1466 and #0660 relating to the comorbidities in Gout at ACR 2020.
Drs. Michael Pillinger, Naomi Schlesinger and Robert Keenan discuss the hot topics in Gout in a panel discussion at ACR 2020.